Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
Baoji Pharmaceutical: KJ103 completes follow-up for Phase III clinical trial of desensitization treatment in kidney transplantation
Baoji Pharmaceutical Co., Ltd. announcement: The Phase III clinical trial of KJ103, used as a desensitization therapy for highly sensitized patients in China awaiting kidney transplantation, has completed the primary trial follow-up for all enrolled subjects as of March 20, 2026. The company said it will submit a new drug marketing application to the National Medical Products Administration as soon as possible.